发明名称 Composition for use in the treatment and prevention of hyperuricemia
摘要 <p>Insulin sensitivity enhancers, such as troglitazone, have the ability to treat and/or prevent hyperuricemia and may thus be used for the therapy or prophylaxis of such diseases as gout, urinary calculus, hyperuricemic nephropathy and Lesch-Nyhan syndrome.</p>
申请公布号 EP0919232(A1) 申请公布日期 1999.06.02
申请号 EP19980309426 申请日期 1998.11.18
申请人 SANKYO COMPANY LIMITED 发明人 FUJIWARA, TOSHIHIKO;IWASAKI, KOICHI;HORIKOSHI, HIROYOSHI
分类号 A61K45/00;A61K31/00;A61K31/40;A61K31/41;A61K31/415;A61K31/42;A61K31/422;A61K31/425;A61K31/426;A61K31/427;A61K31/428;A61K31/437;A61K31/4439;A61K31/506;A61P3/00;A61P19/06;(IPC1-7):A61K31/425 主分类号 A61K45/00
代理机构 代理人
主权项
地址